Human recombinant hyaluronidase is an enzyme that breaks down hyaluronic acid, a component of connective tissue. This breakdown facilitates the absorption and dispersion of co-administered medications, such as local anesthetics or radiopaque agents [1]. It can also be used to increase the volume of injected fluids in subcutaneous tissue [1].
What is hyaluronidase used for in medicine?
Hyaluronidase has several medical applications. It is used as an adjunct to subcutaneous fluid administration to promote rehydration in patients with dehydration [1]. It also enhances the absorption of local anesthetics, allowing for larger volumes to be administered for procedures like dental work or minor surgery [1]. In ophthalmology, it is used to facilitate the dispersion of injected anesthetics for retrobulbar and peribulbar blocks [1]. Additionally, it can be used to enhance the dispersion of radiopaque contrast agents for imaging purposes [1].
How does recombinant hyaluronidase differ from naturally occurring hyaluronidase?
Recombinant hyaluronidase is a synthetically produced enzyme that is identical in structure and function to the hyaluronidase naturally found in the human body [1]. The recombinant form is produced using biotechnology, typically through genetic engineering in cell cultures, ensuring a consistent and pure supply [1].
Are there different types of hyaluronidase products?
Yes, there are different formulations and brand names for hyaluronidase products. Examples include HYQVIA, which combines hyaluronidase with human immunoglobulin G, and Vitrase, which is a purified ovine hyaluronidase [2, 3]. HYQVIA is used for immune globulin replacement therapy in primary immunodeficiency [2].
When does patent exclusivity expire for hyaluronidase products?
Patent expiry dates are specific to individual drug products and their associated patents. Information on patent exclusivity for specific hyaluronidase formulations would need to be consulted through patent databases and drug information resources [4]. For example, DrugPatentWatch.com tracks patent information for various pharmaceuticals [4].
What are the potential side effects of hyaluronidase?
The most common side effects of hyaluronidase are related to the injection site and can include swelling, redness, itching, pain, or a rash [1]. Allergic reactions are possible, though rare [1]. When used with other medications, the side effects of those co-administered drugs can also occur [1].
How is hyaluronidase administered?
Hyaluronidase is typically administered via subcutaneous injection [1]. The method and dosage depend on the intended use and the co-administered substance [1].